SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Por um escritor misterioso

Descrição

Rapid antidepressant effects associated with ketamine have shifted the landscape for the
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDA receptor subunit diversity: impact on receptor properties
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Frontiers Targeting mGlu Receptors for Optimization of
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDA receptor subunit diversity: impact on receptor properties
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
mGlu1 potentiation enhances prelimbic somatostatin interneuron
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDA receptor trafficking in synaptic plasticity and
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
NMDAR-dependent long-term depression is associated with increased
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Dual action of amitriptyline on NMDA receptors: enhancement of Ca
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Applied Sciences January-1 2021 - Browse Articles
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Teste 2nd by Second Digital - Issuu
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Cannabinoids and Vanilloids in Schizophrenia
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Pharmacological treatment of generalized anxiety disorder
de por adulto (o preço varia de acordo com o tamanho do grupo)